Savinskaia A P, Boguslavskaia E V
Biull Eksp Biol Med. 1984 Jan;97(1):79-81.
Experiments on 24 randombred rats with growing lymphosarcoma and mammary carcinoma have demonstrated alterations in steroid-producing function of the ovaries and adrenals and in the estradiol-receptor system. These alterations were found to be inconclusive and dependent on the characteristics of the growing tumor. In rats bearing lymphosarcoma, the reduced estradiol levels in the blood and ovaries were in agreement with a negligible number of cytoplasmic and nuclear receptors in the uterus, mammary glands and tumor. Rats with mammary carcinoma demonstrated an increase in estradiol levels in the blood, ovaries and adrenals and a dramatic fall in the blood progesterone level. In this case the number of cytoplasmic receptors in the uterus and mammary glands decreased, whereas that in the nucleus dramatically rose. The measurement of the number of estradiol molecules in the nucleus and cytoplasm and its correlation to the receptor number made it possible to reveal substantial differences between the estradiol-receptor systems in the two tumors regardless of the low level of receptors in both tumors.
对24只患有进行性淋巴肉瘤和乳腺癌的随机繁殖大鼠进行的实验表明,卵巢和肾上腺的类固醇生成功能以及雌二醇受体系统发生了改变。这些改变被认为是不确定的,并且取决于正在生长的肿瘤的特征。在患有淋巴肉瘤的大鼠中,血液和卵巢中雌二醇水平降低,这与子宫、乳腺和肿瘤中数量可忽略不计的细胞质和核受体相一致。患有乳腺癌的大鼠血液、卵巢和肾上腺中的雌二醇水平升高,而血液中孕酮水平急剧下降。在这种情况下,子宫和乳腺中细胞质受体的数量减少,而细胞核中的数量急剧增加。对细胞核和细胞质中雌二醇分子数量的测量及其与受体数量的相关性,使得有可能揭示两种肿瘤中雌二醇受体系统之间的实质性差异,尽管两种肿瘤中的受体水平都很低。